This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on october 20, 2017.
The actual sample was not returned so a thorough investigation of the reported event could not be performed.
However, retention sample from same lot # venous reservoir filter was obtained.
Visually inspected the retention sample, no anomalies were found.
The sample was then connected to a circuit, and the reservoir clotting test was performed on the retention sample, which included circulating bovine blood through the unit for one hour at a high flow rate (7l/min).
At the completion of the hour, the blood was drained and the unit was rinsed with di water.
There were no clots located within the venous filter.
The reported event was unable to be replicated; therefore, a definitive root cause was not able to be determined.
It is likely that patient conditions contributed to the formations of clots within the reservoir filter.
All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, an hour and 43 minutes into the procedure, the bubble alarm went off and a clot had formed inside the venous return sock on the cardiotomy reservoir.
There was blood loss of 200 cc.
There was a delay for 3 minutes.
The product was changed out.
Procedure was completed successfully.
|